One of the most frequent adverse events after the administration of RTX is hypogammaglobulinemia (both IgM and IgG) (115, 116), which, even if usually asymptomatic, may expose fragile patients to an increased risk of infections even severe (7). The gene discussed is CD40LG; the disease is infection.